Nothing Special   »   [go: up one dir, main page]

Ashino et al., 2012 - Google Patents

Janus kinase (JAK) 3 inhibitor, R256, attenuates allergen-induced airway hyperresponsiveness and airway inflammation in mice

Ashino et al., 2012

Document ID
13226529739719493671
Author
Ashino S
Takeda K
Pine P
Gelfand E
Publication year
Publication venue
B33. ASTHMA THERAPY: NOVEL APPROACHES

External Links

Snippet

Janus Kinase (jak) 3 Inhibitor, R256, Attenuates Allergen-Induced Airway Hyperresponsiveness And Airway Inflammation In Mice RAT Page 1 / Thematic Poster Session / Monday, May 21/8:15 AM-4:30 PM / Area K (Hall D, B33 ASTHMA THERAPY …
Continue reading at www.atsjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50—Control means thereof
    • A61H2201/5058—Sensors or detectors
    • A61H2201/5082—Temperature sensors

Similar Documents

Publication Publication Date Title
Sun et al. Paeoniflorin attenuates allergic inflammation in asthmatic mice
Wang et al. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation
Park et al. Effects of acupuncture on 1‐chloro‐2, 4‐dinitrochlorobenzene‐induced atopic dermatitis
Ashino et al. Janus kinase (JAK) 3 inhibitor, R256, attenuates allergen-induced airway hyperresponsiveness and airway inflammation in mice
Lee et al. Effect of an herbal mixture of Cinnamon Cortex, Persicae Semen, and Natril Sulfas on collagen-induced arthritis and lipopolysaccharides-induced nuclear factor-κ B signaling
Salim et al. Cigarette Smoke Activates JNK in Human Small Airway Epithelial Cells Via the TNF Signaling Pathway.
Melim et al. In vivo characterization of ABT-308, a potent anti-IL-13 antibody for the treatment of asthma
Hwang et al. The Bronchodilator and Nutraceutical Ginger Reduces Lung Inflammation in a Murine Asthma Model
Kennedy et al. Apoptosis Signal Regulating Kinase-1 Promotes Inflammasome Priming In Alveolar Macrophages
Fukuda et al. Angiotensin-Converting Enzyme 2 (ACE2) Activator Attenuates House Dust Mite-Induced Allergic Airway Inflammation in Mice
Ohnishi et al. Interleukin-2-Dependent Induction Of Leukotriene B4 Receptor-1 Through Activation Of Extracellular Signal-Regulated Kinase 1/2 Is Essential For The Development Of CD8+ T Cell-Mediated Airway Hyperresponsiveness And Allergic Airway Inflammation
Rosenthal et al. A Novel Compound That Inhibits S-Nitrosoglutathione Reductase Protects A gainst Experimental Asthma.
Catley et al. Targeting The Immunological Drivers Of Asthma With Inhaled Delivery Of A Jak1 Inhibitor
Gong et al. Melatonin Alleviates Radiation-Induced Lung Injury Via Regulation of Microrna-30e/NLRP3 Axis
Que et al. Systemic And/Or Local Aerosol Inhibition Of S-Nitrosoglutathione Reductase (GSNOR) Ameliorates Physiologic, Biologic, And Proteomic Phenotypes In An Allergic Mouse Model Of Inflammatory Airway Disease
Drake et al. Asthmatic Lung Fibroblasts Produce Increased Levels of TSLP Upon TNFa Stimulation via the ER Stress Response Pathway
Mikami et al. Inhibition of Acetylcholine Esterase Attenuates In Vivo Airway Hyperreactivity and Lung Inflammation in a Model of Murine Asthma
Ito et al. Effects Of RV568, A Narrow Spectrum Kinase Inhibitor, On Human Rhinovirus Replication And Cytokine Production
Namba et al. Combination Of Glycopyrronium And Indacaterol Suppressed Carbachol-Induced Fibrotic Responses In Lung Fibroblasts
Lee et al. Chloroquine, A TAS2R Agonist, Promotes Airway Smooth Muscle Relaxation Despite B2Adrenergic Receptor Tachyphylaxis
Vakhova et al. Modern health technologies in rehabilitation of frequently ill children
Shimizu et al. A Selective NF-kB Inhibitor, DHMEQ, Inhibits Allergic Inflammation in a Murine Model of Asthma.
Kim et al. NADPH Oxidase DUOX2 Mediates Airway Epithelial Immune Response To Fungal Stimuli
Silva et al. Nebulized Lidocaine Is Active On Silica-evoked Airway Inflammation, Lung Remodeling And Respiratory Dysfunction As Administered In The Early But Not In The Late Phase Of Experimental Silicosis In Mice
Edwards et al. ATS Abstract: IKK-ß Is Required For Rhinovirus Induced IFN-ß, IFN-» And Pro-inflammatory Cytokine Production In Vitro And In Vivo